These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38948908)

  • 1. Risk of Cardiovascular Events Associated with Chronic Obstructive Pulmonary Disease and/or Metabolic Syndrome: A Large-Scale Nationwide Population-Based Cohort Study.
    Noh E; Jeong H; Cho IS; Chang MS; Yu I; Park S; Lee JH; Lee SJ; Lee WY; Yong SJ; Kim SH
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1447-1456. PubMed ID: 38948908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs.
    Choi HS; Rhee CK; Park YB; Yoo KH; Lim SY
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2873-2883. PubMed ID: 31849460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, associated factors, and clinical consequences of metabolic syndrome in chronic obstructive pulmonary disease patients: a 5-year prospective observational study.
    Keeratichananont W; Kaenmuang P; Geater SL; Manoret P; Thanapattaraborisuth B
    Ther Adv Respir Dis; 2023; 17():17534666231167342. PubMed ID: 37086118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.
    Ahn HJ; Han KD; Choi EK; Jung JH; Kwon S; Lee SR; Oh S; Lip GYH
    Cardiovasc Diabetol; 2021 Jan; 20(1):20. PubMed ID: 33468142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations.
    Ahn YH; Lee KS; Park JH; Jung JH; Lee M; Jung YJ; Chung WY; Sheen S; Park KJ; Kim DJ; Kang DR; Lee JD; Yoon S; Jin XJ; Yang HM; Lim HS; Park JS; Shin JH; Tahk SJ
    Respiration; 2015; 90(3):199-205. PubMed ID: 26278777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease.
    Kang SY; Lee YH; Jeong SJ; Kim JS; Jeong KH; Hwang HS
    Nephrol Dial Transplant; 2024 Apr; 39(5):778-787. PubMed ID: 37791396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
    Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Syndrome in South Korean Patients with Chronic Obstructive Pulmonary Disease: A Focus on Gender Differences.
    Kim J; Yoo JY; Kim HS
    Asian Nurs Res (Korean Soc Nurs Sci); 2019 May; 13(2):137-146. PubMed ID: 30910730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of multiple comorbidities on mortality in chronic obstructive pulmonary disease among Korean population: a nationwide cohort study.
    Kim Y; Kim YJ; Cho WK
    BMC Pulm Med; 2021 Feb; 21(1):56. PubMed ID: 33573635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Moderate-to-Vigorous Physical Activity and the Risk of Major Adverse Cardiovascular Events or Mortality in People With Various Metabolic Syndrome Status: A Nationwide Population-Based Cohort Study Including 6 Million People.
    Park S; Han K; Lee S; Kim Y; Lee Y; Kang MW; Park S; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    J Am Heart Assoc; 2020 Nov; 9(22):e016806. PubMed ID: 33153387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Forced Vital Capacity and Framingham Cardiovascular Risk Score Beyond the Presence of Metabolic Syndrome: The Fourth Korea National Health and Nutrition Examination Survey.
    Kang HK; Park HY; Jeong BH; Koh WJ; Lim SY
    Medicine (Baltimore); 2015 Nov; 94(47):e2089. PubMed ID: 26632722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.
    Yang HM; Ryu MH; Carey VJ; Kinney GL; Hokanson JE; Dransfield MT; Hersh CP; Silverman EK;
    J Am Heart Assoc; 2024 Jun; 13(11):e033882. PubMed ID: 38818936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Syndrome in Patients with Coexistent Obstructive Sleep Apnea Syndrome and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).
    Archontogeorgis K; Voulgaris A; Papanas N; Nena E; Xanthoudaki M; Pataka A; Schiza S; Rizzo M; Froudarakis ME; Steiropoulos P
    Metab Syndr Relat Disord; 2020 Aug; 18(6):296-301. PubMed ID: 32379990
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).
    Kendzerska T; Leung RS; Aaron SD; Ayas N; Sandoz JS; Gershon AS
    Ann Am Thorac Soc; 2019 Jan; 16(1):71-81. PubMed ID: 30372124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality of patients with chronic obstructive pulmonary disease: a nationwide populationbased cohort study.
    Park SC; Kim DW; Park EC; Shin CS; Rhee CK; Kang YA; Kim YS
    Korean J Intern Med; 2019 Nov; 34(6):1272-1278. PubMed ID: 31610634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population-Based Study.
    Lee SY; Lee SR; Choi EK; Kwon S; Yang S; Park J; Choi YJ; Lee HJ; Moon I; Lee E; Han KD; Cha MJ; Oh S; Lip GYH
    J Am Heart Assoc; 2021 Aug; 10(16):e020901. PubMed ID: 34369167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons.
    Park S; Lee S; Kim Y; Lee Y; Kang MW; Han K; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    Ann Intern Med; 2019 Dec; 171(12):875-884. PubMed ID: 31766057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.